GSK is left as sole bidder amid speculation that the sale is off.
Gene sequencing upstart Oxford Nanopore raises another $140m in its bid to enable the analysis of “any living thing, by anyone, anywhere.”
This week’s news
The chief executive of GlaxoSmithKline has welcomed the breakthrough in talks between the UK and EU27 countries on a transition or ‘implementation’ period.
Mundipharma’s third biosimilar tie-up with Celltrion
Vertex ‘astonished and dismayed’ by NHS rejection
Crackdown follows last year’s declaration of a ‘national emergency’
Up and coming immunotherapy company Autolus has published details of an ‘off switch’ safety features in its next generation CAR-Ts.
New drug is in patient-friendly subcutaneous form